Publications by authors named "Shakeel Virk"

Claim this Profile
A
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper, Shakeel Virk

Breast Cancer Res Treat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet Feilotter, Shakeel Virk

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper, Shakeel Virk

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Prashanth Moku, Lois Shepherd, Suhail M Ali, Kim Leitzel, Wendy R Parulekar, Shakeel Virk

Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and gene alterations.
Lina Chen, Kathrin Tyryshkin, Alison Moore, David W Scott, Christian Steidl, Shakeel Virk

Leuk Lymphoma· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
David L Rimm, Samuel C Y Leung, Lisa M McShane, Yalai Bai, Anita L Bane, Shakeel Virk

Mod Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples.
Alison M Moore, Lee R Boudreau, Shakeel Virk, David P LeBrun

J Vis Exp· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival.
Naif AlJohani, Suk-Jin Choi, Andrew G Day, Abdulmohsen Alhejaily, Shakeel Virk

Leuk Lymphoma· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Shuzhen Liu, Bingshu Chen, Samantha Burugu, Samuel Leung, Dongxia Gao, Shakeel Virk

JAMA Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Diep Ho, Jessica Huang, Judith-Anne W Chapman, Kim Leitzel, Suhail M Ali, Shakeel Virk

Breast Cancer Res Treat· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A Sullivan, Shakeel Virk

Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
Shuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, Mark N Levine, Kathleen I Pritchard, Shakeel Virk

Breast Cancer Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.
Christos S Karapetis, Derek Jonker, Manijeh Daneshmand, Jennifer E Hanson, Christopher J O'Callaghan, Shakeel Virk

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease.
Brianne Wood, Soma Sikdar, Suk Jin Choi, Shakeel Virk, Abdulmohsen Alhejaily

Leuk Lymphoma· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis